Neutrophil Infiltration and Acinar-ductal Metaplasia Are the Main Pathological Findings in Pembrolizumab-induced Pancreatitis-Reference-Cited by-同舟云学术

Neutrophil Infiltration and Acinar-ductal Metaplasia Are the Main Pathological Findings in Pembrolizumab-induced Pancreatitis

Published:2022-12-15 Issue:24 Volume:61 Page:3675-3682
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hirota Morihisa¹,Murakami Keigo²,Koiwai Akinobu¹,Kawamura Keita¹,Yoshino Yuki¹,Takasu Atsuko¹,Kin Ryo¹,Katayama Tomofumi¹,Endo Katsuya¹,Kogure Takayuki¹,Meguro Takayoshi¹,Tabata Toshiharu³,Murakami Kazuhiro²,Satoh Kennichi¹

Affiliation:

1. Division of Gastroenterology, Tohoku Medical and Pharmaceutical University, Japan

2. Division of Pathology, Tohoku Medical and Pharmaceutical University, Japan

3. Division of Chest Surgery, Tohoku Medical and Pharmaceutical University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/24/61_9565-22/_pdf

Reference19 articles.

1. 1. La-Beck NM, Jean GW, Huynh C, Alzghari SK, Lowe DB. Immune checkpoint inhibitors: new insight and current place in cancer therapy. Pharmacotherapy 35: 963-976, 2015.

2. 2. Weber JS, Yang JC, Atkins MB, Disis ML. Toxicities of immunotherapy for the practitioner. J Clin Oncol 33: 2092-2099, 2015.

3. 3. Hofmann L, Forschner A, Loquai C, et al. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effect of anti-PD-1 therapy. Eur J Cancer 60: 190-209, 2016.

4. 4. Abu-Sbeih H, Tang T, Lu Y, et al. Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury. J Immunother Cancer 7: 31, 2019.

5. 5. Hsu C, Marshall JL, He AR. Workup and management of immune-mediated hepatobiliary pancreatic toxicities that develop during immune checkpoint inhibitor treatment. Oncologist 25: 105-111, 2020.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis;Investigational New Drugs;2024-06-03

2. Gradient inflammation in the pancreatic stump after pancreaticoduodenectomy: Two case reports and review of literature;World Journal of Clinical Cases;2024-03-26

3. Autoimmune pancreatitis;The Rose and Mackay Textbook of Autoimmune Diseases;2024

4. Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis;Cancer Letters;2023-12

5. Inflammation and digestive reflux in the pancreatic stump after pancreaticoduodenectomy;2023-04-28